IHH back in the black in Q4 on absence of exceptional items
Singapore
MAINBOARD-listed IHH Healthcare Berhad posted a profit of RM101.26 million (S$34.18 million) in Q4 FY17, reversing losses of RM42.51 million recorded in the corresponding quarter a year ago, which was hit by exceptional items.
In Q4 FY16, the bottom line was weighed down by recognition of forex losses at Acibadem Holdings and an impairment loss on its investment in Gleneagles Khubchan-dani Hospital in India.
TRENDING NOW
One-third of Singapore-listed firms at risk in severe AI downturn: MAS
‘We don’t want to stay as we are’: CEO Patrick Ng builds a more resilient Huationg
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Radiant World table shows six lenders with US$870 million exposure
